Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Current Issues in Molecular Biology
|
June 26, 2026
Advancements in Immune Checkpoint-Based Immunotherapy for Triple-Negative Breast Cancer
Dexian Wei, Yuan Zhang, Yanlin Wu, et al.
Environmental Toxicology
|
August 20, 2023
LncRNA Miat knockdown enhances pirarubicin-mediated anticancer sensitivity in breast cancer cells
Peng Huang, Hongyuan Cheng, Jiahua Ji, et al.
Archives of Gynecology and Obstetrics
|
October 31, 2020
Circular RNA circ_0000043 promotes endometrial carcinoma progression by regulating miR-1271-5p/CTNND1 axis
Dexian Wei, Meirong Tian, Weibo Fan, et al.
Clinical and Experimental Pharmacology & Physiology
|
September 3, 2024
Adenylate cyclase 1 knockdown attenuates pirarubicin-induced cardiotoxicity
Wenqing Zhang, Zhiyun Shu, Peng Huang, et al.
The Journal of Pharmacy and Pharmacology
|
October 17, 2023
Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathway
Peng Huang, Yibing Zhang, Fengjun Wang, et al.
Breast Cancer (Tokyo, Japan)
|
January 9, 2023
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer
Jiulong Ma, Fengjun Wang, Chen Chen, et al.
Iscience
|
May 6, 2024
Erratum: CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
Environmental Toxicology
|
July 20, 2023
LncRNA Miat knockdown protects against pirarubicin-induced cardiotoxicity by targeting miRNA-129-1-3p
Peng Huang, Wenqing Zhang, Jiahua Ji, et al.
Iscience
|
February 16, 2024
CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
International Immunopharmacology
|
January 26, 2023
Icariin alleviates atherosclerosis by regulating the miR-205-5p/ERBB4/AKT signaling pathway
Peng Huang, Fengjun Wang, Yibing Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Current Issues in Molecular Biology
|
June 26, 2026
Advancements in Immune Checkpoint-Based Immunotherapy for Triple-Negative Breast Cancer
Dexian Wei, Yuan Zhang, Yanlin Wu, et al.
Environmental Toxicology
|
August 20, 2023
LncRNA Miat knockdown enhances pirarubicin-mediated anticancer sensitivity in breast cancer cells
Peng Huang, Hongyuan Cheng, Jiahua Ji, et al.
Archives of Gynecology and Obstetrics
|
October 31, 2020
Circular RNA circ_0000043 promotes endometrial carcinoma progression by regulating miR-1271-5p/CTNND1 axis
Dexian Wei, Meirong Tian, Weibo Fan, et al.
Clinical and Experimental Pharmacology & Physiology
|
September 3, 2024
Adenylate cyclase 1 knockdown attenuates pirarubicin-induced cardiotoxicity
Wenqing Zhang, Zhiyun Shu, Peng Huang, et al.
The Journal of Pharmacy and Pharmacology
|
October 17, 2023
Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathway
Peng Huang, Yibing Zhang, Fengjun Wang, et al.
Breast Cancer (Tokyo, Japan)
|
January 9, 2023
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer
Jiulong Ma, Fengjun Wang, Chen Chen, et al.
Iscience
|
May 6, 2024
Erratum: CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
Environmental Toxicology
|
July 20, 2023
LncRNA Miat knockdown protects against pirarubicin-induced cardiotoxicity by targeting miRNA-129-1-3p
Peng Huang, Wenqing Zhang, Jiahua Ji, et al.
Iscience
|
February 16, 2024
CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
International Immunopharmacology
|
January 26, 2023
Icariin alleviates atherosclerosis by regulating the miR-205-5p/ERBB4/AKT signaling pathway
Peng Huang, Fengjun Wang, Yibing Zhang, et al.
Page
of 2